Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

mHealth System for the Self-control of Hyperphosphatemia in Patients With CKD.

NCT05389826 is registered in ClinicalTrials.gov with Hospital Universitari de Bellvitge as lead sponsor.

NCT NCT05389826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05389826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
mHealth System for the Self-control of Hyperphosphatemia in Patients With CKD.
Lead sponsor
Hospital Universitari de Bellvitge
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2022
Completion date
October 15, 2023
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dialysis related complication